Attitudes of florida pharmacists toward implementing a state prescription drug monitoring program for controlled substances

Journal of Managed Care Pharmacy

Volumn 17, Issue 6, 2011, Pages 430-438

  Fass, Jennifer A ^a   Hardigan, Patrick C ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; METHADONE; OXYCODONE; PRESCRIPTION DRUG;

ARTICLE; CROSS-SECTIONAL STUDY; DRUG ABUSE; DRUG LEGISLATION; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; HEALTH CARE PERSONNEL; HEALTH SURVEY; HOSPITAL; HUMAN; MORTALITY; PHARMACIST; PRESCRIPTION; UNITED STATES; ADDICTION; CONFIDENTIALITY; DRUG CONTROL; FACTUAL DATABASE; HEALTH PERSONNEL ATTITUDE; INFORMATION PROCESSING; LEGAL ASPECT; PSYCHOLOGICAL ASPECT;

ATTITUDE OF HEALTH PERSONNEL; CONFIDENTIALITY; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DATABASES, FACTUAL; DRUG AND NARCOTIC CONTROL; FLORIDA; HUMANS; PHARMACISTS; PRESCRIPTION DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84855729560     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2011.17.6.430     Document Type: Article

References (39)

1. U.S. Department of Justice, National Drug Intelligence Center. National prescription drug threat assessment 2009. Executive summary. Document 2009-L0487-001. April 2009. Available at: http://www.justice.gov/ndic/pubs33/33775/execsum.htm#Top. Accessed June 26, 2011.
2. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: volume I. Summary of national findings. NSDUH Series H-38A, HHS Publication No. SMA 10-4586Findings. September 2010. Available at: http://oas.samhsa.gov/NSDUH/2k9NSDUH/2k9ResultsP.pdf. Accessed June 26, 2011.
3. Florida Department of Law Enforcement. Drugs identified in deceased persons by Florida medical examiners 2010 interim report. December 2010. Available at: http://www.fdle.state.fl.us/Content/getdoc/8a59bd00-c38d-4be1-ac06-715a273b552e/MEC-2010-Interim-Report.aspx. Accessed June 26, 2011.
4. The Office of the 45th Governor of Florida Rick Scott. Governor Rick Scott's testimony of prescription drug diversion. April 14, 2011. Available at: http://www.flgov.com/2011/04/14/governor-rick-scott%E2%80%99s-testimony-of-prescription-drug-diversion/. Accessed June 26, 2011.
5. Florida House of Representatives Office of Public Information. On track. June 21, 2011. Available at: http://www.myfloridahouse.gov/Sections/Documents/loaddoc.aspx?DocumentType=Press%20Release&FileName=409. Accessed June 26, 2011.
6. Florida House of Representatives. Enrolled 2011 legislature. SB 2104, 2nd engrossed. Available at: http://www.myfloridahouse.gov/Sections/Documents/loaddoc.aspx?FileName=_s2104er.DOCX&DocumentType=Bill&BillNumber=2104&Session=2011. Accessed June 26, 2011.
7. Florida House of Representatives. 2011 session summary. May 2011. Available at: http://www.myfloridahouse.gov/Sections/Documents/loaddoc.aspx?PublicationType=Session&CommitteeId=&Session=2011&DocumentType=End%20of%20Session%20Summaries&FileName=2011%20End%20 Of%20Session%20Summary.pdf. Accessed June 26, 2011.
8. Florida Office of Drug Control. 2010 transition report. November 10, 2010. Available at: http://drugcontrol.flgov.com/pdfs/Transition_Report-Nov%205.pdf. Accessed June 26, 2011.
9. Florida Office of Drug Control. 2010 annual report. Available at: http://drugcontrol.flgov.com/pdfs/2010_Annual_Report.pdf. Accessed June 26, 2011.
10. Florida Statutes. Chapter 893: drug abuse prevention and control. 893.055 prescription drug monitoring program. Available at: http://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=Ch0893/titl0893.htm&StatuteYear=2009&Title=%2D%3E2008%2D%3EChapter%20 893. Accessed June 26, 2011.
11. Florida Department of Health. Welcome to E-FORCSE: the state of Florida's prescription drug monitoring program. Available at: http://www.doh.state.fl.us/mqa/PDMP/home.html. Accessed June 26, 2011.
12. Florida Department of Health. Florida's prescription drug monitoring program. Fact sheet for healthcare practitioners. Available at: http://www.doh.state.fl.us/mqa/PDMP/docs/Fact%20Sheet-Health%20Care%20 Practitioners.pdf. Accessed June 26, 2011.
13. Florida House of Representatives. Proposed committee bill HHSC 11-04. Available at: http://www.myfloridahouse.gov/Sections/Documents/loaddoc.aspx?PublicationType=Committes&CommitteeId=2593&Session=2011&DocumentType=Proposed%20Committee%20Bills%20 (PCBs)&FileName=PCB%20HHSC%2011-04.pdf. Accessed June 26, 2011.
14. Office of Public Information. OPI Pulse: repeal of the prescription drug monitoring program. March 8, 2011. Available at: http://www.myfloridahouse.gov/Sections/Documents/loaddoc.aspx?DocumentType=Press+Release &FileName=207. Accessed June 26, 2011.
15. Office of the Attorney General of Florida. Attorney General Pam Bondi issues statement on prescription drug monitoring program. April 8, 2011. Available at: http://www.myfloridalegal.com/newsrel.nsf/newsreleases/32EE4B8562546DB78525786C00725C91. Accessed June 26, 2011.
16. National Alliance for Model State Drug Laws (NAMSDL). Prescription drug monitoring programs: a brief overview. March 25, 2011. Available at:http://www.namsdl.org/documents/PMPsBriefOverview3-31-11.pdf. Accessed June 26, 2011.
17. U.S. Department of Justice, Drug Enforcement Administration. Questions and answers: state prescription drug monitoring programs. June 2011. Available at: http://www.deadiversion.usdoj.gov/faq/rx_monitor.htm. Accessed June 26, 2011.
18. National Alliance for Model State Drug Laws. Status of state prescription drug monitoring programs. May 23, 2011. Available at: http://www.namsdl.org/documents/StatusofStates5-23-11.pdf. Accessed June 26, 2011.
19. National Association of Boards of Pharmacy. New Jersey to implement PMP. April 14, 2011. Available at: http://www.nabp.net/news/new-jersey-toimplement-pmp/. Accessed June 26, 2011.
20. National Association of Boards of Pharmacy. Federal funding will support relaunching of Washington PMP. October 1, 2010. Available at: http://www.nabp.net/news/federal-funding-will-support-relaunching-of-washington-pmp/. Accessed June 26, 2011.
21. Washington State Department of Health. Prescription monitoring program. February 25, 2011. Available at: http://www.doh.wa.gov/hsqa/PMP/default.htm. Accessed June 26, 2011.
22. State of Maine, Department of Health & Human Services, Office of Substance Abuse. Maine PMP update. April 28, 2011. Available at: http://www.mnpa.us/handouts/Session%2006c%20-%20PMP%20Update.pdf. Accessed June 26, 2011.
23. Fishbain D, Johnson S, Webster L, Greene L, Faysal J. Review of regulatory programs and new opioid technologies in chronic pain management: balancing the risk of medication abuse with medical need. J Manag Care Pharm. 2010;16(4):276-87. Available at: http://www.amcp.org/data/jmcp/276-287.pdf.
24. Wang J, Christo PJ. The influence of prescription monitoring programs on chronic pain management. Pain Physician. 2009;12(3):507-15. Available at: http://www.painphysicianjournal.com/2009/may/2009;12;507-515.pdf. Accessed June 26, 2011.
25. Curtis LH, Stoddard J, Radeva JI, et al. Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States. Health Serv Res. 2006; 41(3 Pt 1):837-55. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1713206/pdf/hesr041-0837.pdf. Accessed June 26, 2011.
26. Paulozzi LJ, Stier DD. Prescription drug laws, drug overdoses, and drug sales in New York and Pennsylvania. J Public Health Policy. 2010;31(4):422-32.
27. U.S. General Accounting Office. Prescription drugs: state monitoring programs may help to reduce illegal diversion. March 4, 2004. Available at: http://www.gao.gov/new.items/d04524t.pdf. Accessed June 26, 2011.
28. Baehren DF, Marco CA, Droz DE, Sinha S, Callan EM, Akpunonu P. A statewide prescription monitoring program affects emergency department prescribing behaviors. Ann Emerg Med. 2010;56(1):19-23.
29. Katz N, Houle B, Fernandez KC, et al. Update on prescription monitoring in clinical practice: a survey study of prescription monitoring program administrators. Pain Med. 2008;9(5):587-94.
30. Katz N, Panas L, Kim M, et al.; Usefulness of prescription monitoring programs for surveillance-analysis of schedule II opioid prescription data in Massachusetts, 1996-2006. Pharmacoepidemiol Drug Saf. 2010;19(2):115-23.
31. Simeone R, Holland L. An evaluation of prescription drug monitoring programs. September 1, 2006. Available at: http://www.simeoneassociates.com/simeone3.pdf. Accessed June 26, 2011.
32. Blumenschein K, Fink JL, Freeman PR, Kirsh KL, Steinke DT, Talbert J. Independent evaluation of the impact and effectiveness of the Kentucky All Schedule Prescription Electronic Reporting Program (KASPER). October 2010. Institute for Pharmaceutical Outcomes and Policy, University of Kentucky College of Pharmacy. Available at: http://www.chfs.ky.gov/NR/rdonlyres/24493B2E-B1A1-4399-89AD-1625953BAD43/0/KASPEREvaluationFinalReport10152010.pdf. Accessed June 26, 2011.
33. Paulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death rates from drug overdose. Pain Med. 2011;12(5):747-54.
34. Kerlikowske G, Jones CM, Labelle RM, Condon TP. Prescription drug monitoring programs-lack of effectiveness or a call to action? Pain Med. 2011;12(5):687-89.
35. Paulozzi LJ, Logan JE, Hall AJ, McKinstry E, Kaplan JA, Crosby AE. A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction. 2009;104(9):1541-48.
36. Office of the Attorney General of Florida. Attorney General Bondi praises legislature for passing "pill mill" bill. May 6, 2011. Available at: http://www.myfloridalegal.com/newsrel.nsf/newsreleases/A0B437B25C54419985257888007B09A4. Accessed June 26, 2011.
37. Florida Department of Health. Prescription drug monitoring program. Rule hearing: public agenda materials. November 9, 2010. Available at: http://www.eforcse.com/docs/Public_Book_Rule_Hearing_11-9-10.pdf. Accessed June 26, 2011.
38. Ulbrich TR, Dula CA, Green CG, Porter K, Bennett MS. Factors influencing community pharmacists' enrollment in a state prescription monitoring program. J Am Pharm Assoc (2003). 2010;50(5):588-94.
39. Florida Department of Health. Licensee data center. September 2005. Available at: https://ww2.doh.state.fl.us/downloadnet/Licensure.aspx. Accessed June 26, 2011.